Abstract. The aim of this study was to investigate the expression of β-site APP-cleaving enzyme 1 (BACE1) in the hippocampal tissue of an insulin-resistant rat model, and thereby explore the roles of BACE1 and insulin resistance (IR) in the pathogenesis of Alzheimer's disease (AD). A total of 36 male Sprague-Dawley rats, aged 2 months, were randomly divided into three groups. These were an insulin-resistant (experimental) group, a high fat control group and a blank control group. The cognitive function and behavioral changes of the rats were tested by a Morris water maze experiment. Amyloid β (Aβ) deposition was detected by an immunohistochemical method. The expression levels of BACE1 in the rat hippocampal tissues were detected by enzyme-linked immunosorbent assay, western blotting and reverse transcription-quantitative polymerase chain reaction technology. The rats in the experimental group had evident learning and memory impairment, with significantly decreased learning memory. The modeling was successful; in the experimental group, the rats exhibited IR and their glucose metabolism was significantly abnormal. However, there was no characteristic pathology of AD. The expression of BACE1 in the brain tissue of rats in the experimental group was significantly higher than that in high fat control and blank control groups (P<0
Introduction
Alzheimer's disease (AD), with chronic progressive memory, cognitive and other mental retardation as the main clinical manifestations, is an age-related neurodegenerative disease of the central nervous system. The typical pathological changes of AD include the appearance of a large amount of senile plaques due to the accumulation of amyloid β (Aβ) in the brain, neurofibrillary tangles formed by the abnormal phosphorylation of τ protein, and neuronal loss (1) . BACE1 is a cleaving enzyme that generates Aβ protein, which plays a role in the pathogenesis of AD. Sporadic AD (SAD) accounts for 95% cases of AD, but its pathogenesis is not completely clear (2, 3) . Recent studies have shown that AD may be associated with insulin metabolism and signal transduction (4, 5) . Insulin resistance (IR) and hyperinsulinism may play a role in the occurrence and development of SAD (6) .
In the present study, a rat model of IR was used to observe the pathological changes and expression of BACE1 in the brain tissues of insulin-resistant rats, and thereby investigate the roles of BACE1 and IR in the pathogenesis of AD. The results may provide a theoretical basis for the clinical prevention and treatment of AD.
Materials and methods
Animal grouping. A total of 36 male Sprague-Dawley rats, 2 months of age, were provided by the Animal Experimental Center of Zhengzhou University (Zhengzhou, China). All the experimental rats were numbered. Twelve rats were selected as the blank control group using a random digits table. They were fed a normal diet. The remaining 24 rats formed the high fat, high sugar and high protein group. They were fed a high fat, high sugar and high protein diet [percentage of calories: 26% from carbohydrates, 15.12% from protein and 58.18% from fat (refined pig oil)] (7). The IR index was calculated 3 months later by the homeostatic model assessment (HOMA) method: IR = fasting blood glucose x plasmatic insulin/22.5). According to the IR index, the 24 rats were divided into a high fat control group and an experimental group (each n=12). The rats in the experimental group were resistant to insulin (a mean of IR value of 3 standard deviations greater than that in the blank control group was considered to indicate IR). This study was carried out in strict accordance with the recommendations in the Guide for the Care 
Enzyme-linked immunosorbent assay (ELISA).
A 100 mg portion of the rat hippocampus was isolated by excision and, in a ratio of 20 mg/200 µl, the corresponding volume of cell lysis buffer (50 mM Tris pH 7.4, 250 mM NaCl, 0.5% Triton X100, 10% glycerol and 1 mM DTT; Roche, Indianapolis, IN, USA) was added to the brain mass. The tissue was homogenized in an ice bath with ultrasonic irradiation. After 30 min, the homogenate was centrifuged for 15 min at 15,000 x g and 4˚C.
The supernatant was extracted in order to determine the concentration of protein. The protein was assayed using a BACE1 ELISA kit (Roche, Indianapolis, IN, USA) according to the manufacturer's instructions. All experiments for each sample were performed in triplicate.
Western blot analysis. The sample was added to the supernatant extracted as described above, 5X loading buffer was added and the mixture was boiled for 10 min, then centrifuged at 15,000 x g for 5 min. The proteins were extracted, subjected to SDS-PAGE and then transferred to a nitrocellulose membrane, where they were blocked with 5% bovine serum albumin in phosphate-buffered saline Tween-20 solution for 30 min. Rabbit anti-human BACE1 polyclonal antibodies (#L4391; Wuhan Boster Biological Technology, Ltd., Wuhan, China) diluted with Tris-buffered saline (TBS) and Tween 20 (TBST; 1:2,000) were added, and the membrane was incubated overnight at 4℃. After rinsing, goat anti-rabbit IgG polyclonal antibodies (#554020; BD Biosciences, Franklin Lakes, NJ, USA) diluted with TBST (1:100) were added and the membrane was incubated at room temperature for 1 h. After rinsing, the membrane was stained with DAB in the dark. When the color was developed satisfactorily, TBS was added to terminate the reaction. The strips of film were analyzed using a gel image analyzer (Tocan 240; Tocan Biotechnology Co., Shanghai, China). β-actin (with TBST, dilution 1:500) was used as the internal reference protein.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
A 100-mg quantity of frozen hippocampal tissue was excised in order to extract the total RNA. cDNA was synthesized by reverse transcription using a First Strand cDNA Synthesis kit with M-MLV reverse transcriptase (Takara, Dalian, China). The thermal cycling conditions were 65˚C for 5 min, 25˚C for 5 min, 42˚C for 60 min and 70˚C for 5 min. The cDNA synthesis product (0.5 µl) was amplified by PCR. For BACE1, the upstream primer F1 was 5'-CCT CCG AAA GTC TGT GTA TGTG-3' , the downstream primer R1 was 5'-CAG TTG GAA CCA TTG ATG AAGA-3', and the product was a fragment of 159 bp. β-actin was chosen as the internal reference; the upstream primer F2 was 5'-TCG TGC GTG ACA TTA AGG AG-3' and the downstream primer R2 was 5'-ATG CCA GGG TAC ATG GAT TG-3'. The target gene and internal reference gene were amplified using an ABI 7500 Real-Time PCR instrument (Applied Biosystems, Foster City, CA, USA). The thermal cycling conditions were set as 50˚C for 2 min, 95˚C for 10 min and then 40 cycles of 95˚C for 5 min, 94˚C for 15 sec, 60˚C for 30 sec and 72˚C for 30 sec. The specimens with the highest content were diluted by 1:1, 1:10, 1:100, 1:1,000, 1:10,000, respectively, in order to perform the amplification by PCR and standard curves were drawn. All experiments for each sample were performed in triplicate.
Statistical analysis. Statistical analysis was conducted using SPSS software, version 17.0 (SPSS Inc., Chicago, IL, USA). The measurement data are represented as mean ± standard deviation. The means between multiple groups were compared by single factor analysis of variance. The least significant difference method was applied in pairwise comparisons.
Results

Comparison of IR indices among the groups.
The IR index in the rats of the blank control group was 25.85±3.66. According to the standards used when establishing the groups, the rats fed with a high fat, high sugar and high protein diet whose IR indices were >36.83 were regarded as the experimental group. The remainder of the rats fed with a high fat, high sugar and high protein diet were regarded as the high fat control group. The fasting blood glucose and insulin values of the rats were measured at the end of the experiment in order to calculate the IR index (Table I) .
Morris water maze test. In the Morris water maze test, results for the average escape latency period of rats are presented in Table II . The average escape latency to find the platform for the experimental group rats was significantly higher than that for the blank control and high fat control groups (P<0.01). The number of times the rats crossed the platform in the experimental group was significantly decreased compared with that in the high fat control group (P<0.01). There was no difference in the number of crossings between the rats in the high fat control group and those in the blank control group (P>0.05; data not shown).
Immunohistochemical results.
The immunohistochemical results demonstrated that a slight deposition of Aβ was present in the brains of rats in the high fat control group, while the Aβ deposition was evident in the brains of rats in the experimental group. The deposition could be observed both inside and outside the cells. However, the presence of senile plaques due to the aggregation of Aβ dispersed within the hippocampus was not observed (Fig. 1) .
Results of BACE1 detection by ELISA.
ELISA results evaluating the levels of BACE1 are shown in Table III . The amount of BACE1 in the hippocampus of rats in the experimental group was significantly higher than that in the blank control and high fat control groups (P<0.01).
Results of BACE1 detection by western blotting.
The expression of BACE1 in the cerebral tissue of the rats in each group was detected by western blotting. It was observed that BACE1 was expressed in the cerebral tissue of the rats in each group. The expression of BACE1 in the experimental group was significantly higher than that in the other two groups (P<0.01; Table IV) .
Results of BACE1 detection by RT-qPCR. The mRNA expression level of BACE1 was calculated by RT-qPCR analysis.
The expression level of BACE1 mRNA in the hippocampus of rats in the experimental group was significantly higher than that in the blank control and high fat control groups (P<0.01; Table V) .
Discussion
AD is a degenerative disease of the nervous system associated with multiple factors. The pathogenesis of AD is not very clear; however, the amyloid protein cascade hypothesis is an acceptable hypothesis to a large number of scholars at present (9) . It considers that the deposition of Aβ is the originating factor of AD. Certain studies have shown that the cerebral glucose metabolic rate and energy production are significantly decreased in patients with AD (10,11). Dysfunction of insulin and the insulin receptor signal transduction system plays an important role in the pathological process of AD (12) . This is associated with the cerebral glucose oxidative metabolism and energy production (13), the over-phosphorylation of τ protein (14) , cell apoptosis in easily affected brain regions (15) and the aggregation of Aβ in cells (16), followed by a deficiency of energy metabolism, acetylcholine imbalance and neuronal apoptosis that eventually lead to dementia. BACE1 is a β secretory enzyme, and a rate-limiting enzyme in the production of Aβ. It degrades β amyloid precursor protein (APP) to form Aβ (17) . A large number of studies have demonstrated that inhibition of the expression of BACE1 may control AD (18, 19) . Therefore, there appears to be a close association between BACE1 and AD.
STZ is a nitrosourea derivative. It blocks the autophosphorylation of the insulin receptor and intrinsic tyrosine kinase activity in the main center of the brain and influences the function of the insulin receptor. Once the insulin/insulin receptor system is destroyed, the metabolism of nerve cells in the cerebral cortex and hippocampus is likely to be affected (20) . The disturbance of glucose metabolism leads to a reduction of ATP production in affected cells. The intracerebroventricular injection of small dose of STZ can lead to the reduction of cerebral insulin levels while not affecting insulin in the peripheral circulation. This can induce IR in the central nervous system and the development of progressive neurodegenerative disease, leading to the development of dementia (21) . The STZ-induced animal model has many similarities with the clinical manifestations and pathological changes of AD. The animal model has become an important model for performing 'insulin-AD' relevant research (21, 22) . In the present study, the rats were fed with a high fat, high sugar and high protein diet for 12 weeks to induce IR in the rats of the experimental group. An intracerebroventricular injection of a small dose of streptozotocin was then administered. The model is consistent with the clinical situation. Following the establishment of the model, the learning changes of the rats were detected by Morris water maze test in each group. The latency period in searching for the platform in the rats in the experimental group was significantly longer than that in the high fat control group (P<0.01). There was no significant difference in latency period between the high fat control and control groups (P>0.05). The number of times the rats in the experimental group crossed the platform was significantly decreased compared with that in the high fat control group (P<0.01); however, there was no difference between the rats in the high fat control and blank control groups (P>0.05). This suggests that the model of dementia induced by IR was successful.
Histopathological examination of the brains of rats in the experimental group indicated that there were no pathological changes characteristic of AD. The results of ELISA, western blotting and RT-qPCR revealed that the hippocampal content of the BACE1 enzyme and the expression of BACE1 mRNA in the rats of the experimental group were higher compared with those in the high fat control and blank control groups, and the difference was statistically significant (P<0.01). However, there was no significant difference in BACE1 level between the high fat control and blank control groups (P>0.05). Thus it may be assumed that IR led to the increase of BACE1 expression in insulin-resistant rats, and was involved in the pathogenesis of AD. However, for the rats in the experimental group, no characteristic pathological changes of AD were detected in the brain by histopathological analysis. It is speculated that the possible reason was that it is a comparatively long process from the occurrence of IR to the appearance of the characteristic pathology of AD. Considering the body as a whole, in addition to the BACE1 enzyme which increases Aβ levels, there are also enzymes that can clear Aβ. Both are able to maintain a dynamic balance to a certain extent. Therefore, BACE1 is just one of the enzymes influencing the metabolism of Aβ, and may not necessarily lead to a pathological change of a certain extent at a specific time.
In addition, studies have shown that the occurrence of SAD is caused by multiple factors, such as redundant Aβ production, hyperphosphorylation of τ protein, generation of free radicals and oxidative stress damage (23) (24) (25) , inflammatory factors, individual biological characteristics, past disease history/complications, habits, dietary habits, contact with certain substances or environments and social/psychological factors. 
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In summary, the present study found increased expression levels of BACE1 in the brain tissue of rats with IR. It also indicated that IR is involved in the pathogenesis of AD from a single aspect. The specific mechanism of IR in the pathogenesis of AD requires further study.
